Eli Lilly and Company
LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$924.37
Price-1.40%
-$13.07
1Y
Price
Market Cap
$830.348b
Large
Price/Earnings 3y Avg5y Avg
45.2x
Premium
Premium
Financials Overview
Key metrics over the past few years+43.8%
EBITDA Margin+31.7%
Net Profit Margin+48.9%
Free Cash Flow MarginRevenue
$59.420b
+31.9%
1y CAGR+27.8%
3y CAGR+21.1%
5y CAGREarnings
$18.412b
+73.9%
1y CAGR+53.3%
3y CAGR+42.9%
5y CAGREPS
$20.44
+74.6%
1y CAGR+54.9%
3y CAGR+44.3%
5y CAGRBook Value
$23.851b
$114.935b
Assets$91.085b
Liabilities$42.507b
DebtDebt to Assets
37.0%
1.7x
Debt to EBITDAFree Cash Flow
$9.021b
+2077.3%
1y CAGR+674.0%
3y CAGR+501.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company